Brief: Clarity Pharmaceuticals Enters Commercial Manufacturing Agreement
17/06/2025 02:31
June 17 (Reuters) - Clarity Pharmaceuticals Ltd CU6.AX: ENTERS A COMMERCIAL MANUFACTURING AGREEMENT FOR CU-64 SAR-BISPSMA WITH SPECTRONRX Further company coverage: CU6.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Clarity Pharmaceuticals
See all newsBrief: Clarity Pharmaceuticals Signs Commercial Manufacturing Agreement
Brief: Clarity Signs A Large-Scale Manufacturing Supply Agreement For Copper-64 With Theragenics
Brief: Clarity Pharmaceuticals Signs A Large-Scale Manufacturing Supply Agreement
Australia's Clarity Pharmaceuticals rises on bagging cancer detection agent supply
Australia's Clarity Pharma surges as US FDA approves trial